Karrieregespräch mit Dr. Martin M. Rudolph, Validierungsmanagement bei Biotest

Centre biomed firstzeichenfla %c3%aache 3 s

8. Dezember 2022 | 16:30 Uhr | Deutsch | Online

Mehr Information zu Dr. Martin M. Rudolph:

Dr. Martin M. Rudolph leitet zurzeit eine Gruppe mit 7 Mitarbeitenden bei der Biotest AG in Dreieich. Sein Team ist hier für die Validierung neuer und bestehender Herstellprozesse für Blutplasmaprodukte verantwortlich.
Doch wie kam er zu dieser Position und inwiefern half ihm sein Studium und seine Promotion dabei?
 
Dr. Martin M. Rudolph studierte Biologie mit der Spezialisierung Mikrobiologie, Genetik und pharmazeutische Biologie an der FSU Jena. Nach seiner Diplomarbeit und anschließenden Tätigkeit am Leibniz-Institut für Naturstoffforschung und Infektionsbiologie nahm er 2011 an die Goethe-Universität sein Promotionsstudium in der Arbeitsgruppe RNA-Biochemie bei Prof. Dr. Beatrix Süß auf. Dieses setzte wegen des Umzuges der Arbeitsgruppe ab 2012 an der TU Darmstadt fort. Nach der Promotion 2015 forschte er bis 2016 als PostDoc im EU-Projekt PROMYS in der Arbeitsgruppe bei Beatrix Süß.
Im Jahr 2017 erfolgte sein Wechsel in die pharmazeutische Industrie.  Über eine Consulting-Firma arbeitete Herr Rudolph bei Sanofi-Aventis im Industriepark Höchst als Projektmanager für Validierung/Qualifizierung. Im gleichen Jahr wechselte er dann zur Biotest AG, wo er als Validation Manager angestellt war. Ab 2020 nahm er in seiner Abteilung eine Gruppenleiterposition für das gesamte Validierungsmanagement der bestehenden Bulk-Produktion ein; Ende 2021 übernahm er sein jetziges Team für die neu aufzubauende Bulk-Produktion.
 
Im Karrieregespräch wird Herr Rudolph auf die Ansprüche an akademisch gebildete Mitarbeitende in der Pharma-Industrie eingehen. Er wird zeigen, wie wichtig Fachwissen und Soft-Skills sind und was man beachten muss, um eine Führungslaufbahn einzuschlagen.

Excursion to Sanofi, Frankfurt-Höchst

Centre biomed firstzeichenfla %c3%aache 3 s

23. November 2022 | 9:00 – approx. 12:30

“Meet the expert” & bus tour across the site


Career Talk with Dr. Sarah Oelsner: Managing partner at Scitaris, a pharma and biotech R&D consulting

Centre biomed firstzeichenfla %c3%aache 3 s

29. November 2022 | 4:00 pm | English | Online

More Information about Dr. Sarah Oelsner (Scitaris):

Sarah started her career with studying Pharmacy at the University of Heidelberg, and Molecular Genetics in Zaragoza, Spain. As she has always been curious to understand the biopharma industry from different perspectives, she worked for several years as a hospital and community pharmacist and later moved on to join the department of Immunology & Respiratory Diseases at the Novartis Institutes of Biomedical Research (NIBR), Basel. Driven by her passion for translational research, Sarah dedicated her PhD to Immuno-Oncology where she developed various novel chimeric antigen receptor (CAR)-modified lymphocytes in the group of Prof. Winfried Wels at the Georg-Speyer-Haus in Frankfurt.

She then moved into strategy consulting for several years, which made her notice the often limited science-driven decision-making in the biotech/pharma industry. This led Sarah and 2 other colleagues to found Scitaris in April 2019 – a boutique R&D life science strategy consultancy based in Berlin & Boston. The unifying conviction at Scitaris is that in the complex world of biopharma R&D, deep scientific and clinical understanding drive all viable business strategies and are crucial to successfully bring value to patients, drug developers and society.

Scitaris today has grown to a team of 22 international PhD scientists supporting biopharma companies in the US and Europe from answering focused strategic and technical questions around single assets to full-blown portfolio management and corporate strategy. Sarah will provide an overview of the range of projects Scitaris is working on and what expects you when moving from academia to a consulting career.

-----------------------

Scitaris currently offers several entry-level positions for recent PhD graduates and PostDoc with relevant Life Science background (biology, chemistry, biochemistry, pharmacy, medicine, bioinformatics etc.). Please submit your CV and cover letter to careers@scitaris.com until January 15th, 2023.

Open to those interested in all disciplines!


Dr. Larissa Dorsch – Brand Manager

Centre biomed firstzeichenfla %c3%aache 3 s

30 May 2022| 16:30 | Online | GRADE Center BioMedFIRST

Dr. Larissa Dorsch has a background in molecular medicine and tumour biology. For her PhD, she moved to Amsterdam to study the protein quality control and microtubule network in inherited cardiomyopathies.

To explore different job opportunities in the pharmaceutical industry and to build a broad network, she applied for a Medical-Marketing-Sales trainee programme last year.  She first got trained as a Medical Manager for an over-the-counter (OTC) product. Since the beginning of this year, she works in the brand team for an Rx product.

Larissa will provide information about the differences and challenges of working as a brand manager for OTC and Rx drugs.  Furthermore, she will talk about which transferable skills from her PhD she now uses in her daily work.

All interested are very welcome!


Dr. Miriam Walter - Senior Medical Writer at nspm ltd. in Meggen, Switzerland

Centre biomed firstzeichenfla %c3%aache 3 s

12 May 2022| 17:00 | Online | GRADE Center BioMedFIRST

Miriam Walter is a pharmacist by training and did her PhD in pharmaceutical chemistry in the laboratory of Prof. Stark at the Goethe University Frankfurt, during which time she was also enrolled to the FIRST Graduate School.

Through her PhD she discovered a passion for writing and joined nspm ltd, a medical communications agency with offices in Switzerland and the UK, as Medical Writer soon after finishing her doctorate thesis. In her job, she develops scientifically rigorous and engaging content for various disease areas and clients in the biopharmaceutical sector and supports successful scientific educational events for her clients.

In a nutshell, medical writing is the translation of scientific and clinical data into various formats tailored to specific target audiences, including physicians, nurses, representatives of health care authorities or insurance companies, and patients.

With now 10 years of experience working in the industry, she will give insights into what medical writing is, requirements to become a medical writer, and what to expect when working in a medical communications agency.

All interested are very welcome!


Dr. Annika Ranglack-Wagner - Qualitätssicherung und Validierung bei R-Biopharm AG

Centre biomed firstzeichenfla %c3%aache 3 s

5. April 2022 | 16:00 | online via zoom | GRADE Center BioMed FIRST

Dr. Annika Ranglack-Wagner hat nach dem Biologiestudium an der TU Darmstadt in der Arbeitsgruppe von Prof. Radeke am FB16 (GU) ihre Promotionsarbeit durchgeführt und an der TU Darmstadt promoviert.  Anschließend hat sie 3 Monate als Studienkoordinatorin gearbeitet bevor sie zur R-Biopharm AG, Darmstadt, in den Bereich Qualifizierung und Validierung gewechselt ist. 

Seit Oktober 2020 ist sie als Validierungsspezialistin für Computergestützte Systeme tätig. Anfang des Jahres hat sie zusätzlich die stellvertretende Gruppenleitung der Gruppe Qualitätssicherung für Arbeitsumgebung und Infrastruktur übernommen. 

Die R-Biopharm AG ist eines der führenden Biotechnologieunternehmen Deutschlands und bietet Produkte und Lösungen im Bereich der Analytik in Prävention, Therapie und Heilung. 


Dr. Lena Dorsheimer – Trainee program at Sanofi

Centre biomed firstzeichenfla %c3%aache 3 s

March 29 | 16:30 | online via zom | GRADE Center BioMed FIRST

Together with Provadis Partner für Bildung und Beratung, Sanofi offers a two-year trainee program as an entry into the pharmaceutical industry for various professional groups. On the one hand, Dr. Lena Dorsheimer will talk about her experiences as a laboratory manager and operations assistant in the production, as well as her role as risk manager for medical devices. She will also discuss what the trainee program can offer, and her impressions compared to academic research.

Dr. Lena Dorsheimer did her PhD project at the FB16 in the group of Prof. Michael Rieger.


Dr. Kathrin Körner - global head of patents and scientific information services at Merck KGaA

Centre biomed firstzeichenfla %c3%aache 3 s

February 3, 2022 | 16:30 | online via zoom | GRADE Center BioMed FIRST

Dr. Kathrin Körner is global head of patents and scientific information services at Merck KGaA. She studied Human Biology at the Philipp University Marburg, holds a PhD in Molecular Biology, is qualified as German and European Patent and Trademark Attorney and holds a Diploma in European Patent Litigation.

When writing her PhD in Molecular Biology she realized that her professional preference would be a combination of science and language, that she did not want to pursue a career involving bench work and decided to become a patent attorney. Kathrin will provide information about the career path in the patent field and share some insights on dos and don’ts in the professional life based on her own personal experience and mistakes along the way.